Noubar Afeyan, Director at Moderna, Inc. (MRNA), sold 9,263 shares at $46.84 ($434K) on 2026-05-21, disclosed to the SEC on 2026-05-22.
Open-market sale of $434k MRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRNA | SELL | 2024-08-02 | $3.6M | — | Filing → |
| MRNA | SELL | 2024-07-26 | $2.9M | — | Filing → |
| MRNA | SELL | 2024-07-19 | $3.0M | — | Filing → |